Wealth Management Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Buy
1,239
+2
+0.2% +$2.04K 0.58% 17
2026
Q1
$1.14M Buy
1,237
+2
+0.2% +$2.03K 0.51% 17
2025
Q4
$1.33M Buy
1,235
+2
+0.2% +$1.91K 0.61% 16
2025
Q3
$941K Buy
1,233
+3
+0.2% +$2.23K 0.47% 19
2025
Q2
$959K Buy
1,230
+2
+0.2% +$1.55K 0.52% 17
2025
Q1
$1.01M Buy
1,228
+2
+0.2% +$1.66K 0.68% 16
2024
Q4
$946K Buy
+1,226
New +$1.02M 0.72% 16

Other funds holding LLY

Wealth Management Strategies's LLY Position: Q2 2026 in Review

Wealth Management Strategies increased its Eli Lilly (LLY) stake by 0.16% in Q2 2026, buying an estimated $2.04K and bringing the position to 1,239 shares worth $1.49M. The position accounts for 0.58% of the portfolio, ranked #17.

Wealth Management Strategies first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wealth Management Strategies held 1,239 shares of Eli Lilly worth $1.49M as of Q2 2026.
  • Wealth Management Strategies bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.58% of Wealth Management Strategies's portfolio in Q2 2026, its #17 holding.
  • Wealth Management Strategies first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wealth Management Strategies's 13F filing for Q2 2026, filed 17 Aug 2026.